BACKGROUND: Atrial, brain, and C-type natriuretic peptides (ANP, BNP, and CNP) are important in regulating a variety of cardiovascular and cellular functions. In cells, these peptides are made as proforms that are converted to mature forms. BNP and its related peptides are biomarkers for the diagnosis of heart failure. In this study, we examined glycosylation in pro-ANP, pro-BNP, and pro-CNP, which may alter their biochemical and metabolic properties. METHODS: Human pro-ANP, pro-BNP, and pro-CNP were expressed in HEK 293 cells and murine HL-1 cardiomyocytes and analyzed by immunoprecipitation and Western blotting. We used deglycosylation enzymes to determine the carbohydrate content on these peptides and examined the effects of inhibiting O-glycosylation on cellular expression and stability of the peptides. RESULTS: In HEK 293 and HL-1 cells, pro-BNP, but not pro-ANP and pro-CNP, from the culture medium had a greater molecular mass than that from cell lysate. Digestion with PNGase F, O-glycosidase, and sialidase A indicated that pro-BNP contained O-glycans but not N-glycans. The O-glycans on pro-BNP had sialic acids at their termini, protecting it from O-glycosidase digestion. In contrast, pro-ANP and pro-CNP contained no detectable amounts of N- or O-glycans. Inhibition of O-glycosylation on pro-BNP did not prevent its expression in the cells. However, partially O-glycosylated pro-BNP was much less stable than fully O- glycosylated pro-BNP. CONCLUSIONS: O-glycosylation is not necessary for pro-BNP expression but important for its stability.
BACKGROUND: Atrial, brain, and C-type natriuretic peptides (ANP, BNP, and CNP) are important in regulating a variety of cardiovascular and cellular functions. In cells, these peptides are made as proforms that are converted to mature forms. BNP and its related peptides are biomarkers for the diagnosis of heart failure. In this study, we examined glycosylation in pro-ANP, pro-BNP, and pro-CNP, which may alter their biochemical and metabolic properties. METHODS:Humanpro-ANP, pro-BNP, and pro-CNP were expressed in HEK 293 cells and murineHL-1 cardiomyocytes and analyzed by immunoprecipitation and Western blotting. We used deglycosylation enzymes to determine the carbohydrate content on these peptides and examined the effects of inhibiting O-glycosylation on cellular expression and stability of the peptides. RESULTS: In HEK 293 and HL-1 cells, pro-BNP, but not pro-ANP and pro-CNP, from the culture medium had a greater molecular mass than that from cell lysate. Digestion with PNGase F, O-glycosidase, and sialidase A indicated that pro-BNP contained O-glycans but not N-glycans. The O-glycans on pro-BNP had sialic acids at their termini, protecting it from O-glycosidase digestion. In contrast, pro-ANP and pro-CNP contained no detectable amounts of N- or O-glycans. Inhibition of O-glycosylation on pro-BNP did not prevent its expression in the cells. However, partially O-glycosylated pro-BNP was much less stable than fully O- glycosylated pro-BNP. CONCLUSIONS: O-glycosylation is not necessary for pro-BNP expression but important for its stability.
Authors: H Chusho; N Tamura; Y Ogawa; A Yasoda; M Suda; T Miyazawa; K Nakamura; K Nakao; T Kurihara; Y Komatsu; H Itoh; K Tanaka; Y Saito; M Katsuki; K Nakao Journal: Proc Natl Acad Sci U S A Date: 2001-03-20 Impact factor: 11.205
Authors: Alan S Maisel; Padma Krishnaswamy; Richard M Nowak; James McCord; Judd E Hollander; Philippe Duc; Torbjørn Omland; Alan B Storrow; William T Abraham; Alan H B Wu; Paul Clopton; Philippe G Steg; Arne Westheim; Catherine Wold Knudsen; Alberto Perez; Radmila Kazanegra; Howard C Herrmann; Peter A McCullough Journal: N Engl J Med Date: 2002-07-18 Impact factor: 91.245
Authors: John G Lainchbury; Elizabeth Campbell; Christopher M Frampton; Timothy G Yandle; M Gary Nicholls; A Mark Richards Journal: J Am Coll Cardiol Date: 2003-08-20 Impact factor: 24.094
Authors: Alexander G Semenov; Alexander B Postnikov; Natalia N Tamm; Karina R Seferian; Natalia S Karpova; Marina N Bloshchitsyna; Ekaterina V Koshkina; Mihail I Krasnoselsky; Daria V Serebryanaya; Alexey G Katrukha Journal: Clin Chem Date: 2009-01-23 Impact factor: 8.327
Authors: Susan P Wright; Robert N Doughty; Ann Pearl; Greg D Gamble; Gillian A Whalley; Helen J Walsh; Gary Gordon; Warwick Bagg; Helen Oxenham; Tim Yandle; Mark Richards; Norman Sharpe Journal: J Am Coll Cardiol Date: 2003-11-19 Impact factor: 24.094
Authors: Jason M Tonne; Jarryd M Campbell; Alessandro Cataliotti; Seiga Ohmine; Tayaramma Thatava; Toshie Sakuma; Fima Macheret; Brenda K Huntley; John C Burnett; Yasuhiro Ikeda Journal: Clin Chem Date: 2011-04-11 Impact factor: 8.327
Authors: Katrine T-B G Schjoldager; Malene B Vester-Christensen; Eric Paul Bennett; Steven B Levery; Tilo Schwientek; Wu Yin; Ola Blixt; Henrik Clausen Journal: J Biol Chem Date: 2010-09-13 Impact factor: 5.157